Lenire ®.

Panakès Partners is an Equity capital firm, based in Milan, which buys one of the most enthusiastic companies and groups, establishing cutting edge technologies and Bookmarks products, in the field of life sciences, aiming to boost the lives of individuals around the world.

Neuromod, which announced that FDA authorization at a joint protection and veteran audiology meeting in the United States has already received its initial US order and the initial delivery from its Letterkenny-based production companion, Philips-Medisize, was en path today.

Given that the previous round of funding increased in October 2020, the company has actually made progression commercialising Lenire, increasing the device's schedule throughout Europe, developing an entirely had United States subsidiary, Neuromod USA Inc, and protecting US market authorization from the FDA.

The first of these tests, TENT-A1, stands for among the biggest and longest followed-up professional trials ever carried out in the tinnitus field and was the cover tale for the clinical journal Scientific research Translational Medication in October 2020.